Background: Antibodies targeted at the SARS-CoV2 spike protein are an essential part of the body’s immune response to COVID19 infection. The recent emergency use authorization … Continue reading No Evidence that REGN-COV2 (Regeneron) Antibody Cocktail Has Clinical Benefits